CYP1A2 rs762551: What Your Genotype Means for Caffeine Metabolism
The rs762551 variant in the CYP1A2 gene is a well-studied genetic marker that influences the speed at which your liver metabolizes caffeine. Depending on your genotype, you may be classified as a fast or slow metabolizer, which can affect how caffeine impacts your body.
What each genotype means
Fast caffeine metabolizer
Research suggests that individuals with this genotype may have higher inducibility of the CYP1A2 enzyme, potentially leading to faster caffeine clearance. Some studies indicate that this genotype may be associated with a larger ergogenic effect from caffeine during exercise, though results can be mixed and influenced by other factors like smoking status. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
This genotype is common in most populations, though exact frequencies vary by ancestry.
Slow caffeine metabolizer
This genotype is often associated with slower caffeine metabolism compared to the AA genotype, particularly in the presence of enzyme inducers like smoking or heavy coffee consumption. Some research suggests that individuals with this genotype may have an increased risk of certain health markers, such as hypertension or kidney dysfunction, when consuming high amounts of caffeine. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
This genotype is common in most populations, though exact frequencies vary by ancestry.
Slow caffeine metabolizer
Individuals with this genotype are generally categorized as slower caffeine metabolizers, as the C allele is associated with decreased enzyme activity and inducibility. Research indicates that heavy coffee consumption in slow metabolizers may be linked to a higher risk of certain health outcomes, such as albuminuria or hypertension. Please discuss your caffeine intake and any health concerns with your clinician or pharmacist.
This genotype is common in most populations, though exact frequencies vary by ancestry.
Understanding the rs762551 Variant
The rs762551 variant is a single nucleotide polymorphism (SNP) located within the CYP1A2 gene. This gene provides instructions for making the cytochrome P450 1A2 enzyme, which is primarily responsible for breaking down various substances in the liver, including approximately 95% of the caffeine consumed by humans. The variant involves a substitution of the nucleotide adenine (A) to cytosine (C) at a specific position in the gene. This change is significant because it alters the inducibility and activity level of the enzyme. Research indicates that the C allele is associated with decreased enzyme activity compared to the A allele. Because this enzyme is the primary pathway for caffeine clearance, this small genetic difference can lead to noticeable variations in how long caffeine remains active in an individual's system.
The Role of CYP1A2 in Caffeine Metabolism
CYP1A2 is a critical enzyme in the cytochrome P450 family, which is essential for the metabolism of many drugs and dietary compounds. When you consume coffee, tea, or other caffeinated products, the CYP1A2 enzyme works to break down the caffeine molecule so it can be excreted from the body. Individuals with the 'fast metabolizer' genotype (AA) produce an enzyme that clears caffeine from the bloodstream more efficiently. Conversely, those with the 'slow metabolizer' genotypes (AC or CC) have reduced enzyme activity, meaning caffeine persists in their system for a longer duration. This difference in metabolic rate is why some people can consume coffee late in the day without sleep disruption, while others may experience jitteriness or insomnia even after moderate intake. It is important to note that while genetics play a major role, other factors such as smoking, age, and sex also influence overall CYP1A2 activity.
Research and Health Associations
Scientific research has extensively investigated the link between rs762551 and various health outcomes. Studies have suggested that the impact of caffeine on health markers—such as blood pressure, glucose levels, and kidney function—may differ based on an individual's metabolic rate. For example, some research indicates that heavy coffee consumption might be associated with an increased risk of certain health issues specifically in slow metabolizers, as the prolonged presence of caffeine may exert different physiological effects compared to fast metabolizers. However, the evidence is complex and often depends on the specific health outcome being measured. It is crucial to understand that these findings represent statistical associations across large populations rather than individual medical predictions. If you are concerned about how your caffeine intake affects your health, you should discuss your habits and any symptoms with your clinician or a registered dietitian.
What You Can and Cannot Do With This Information
Knowing your genotype for rs762551 can provide insight into why you might react to caffeine differently than others. If you identify as a slow metabolizer, you might find that you are more sensitive to the stimulating effects of caffeine and may choose to limit your intake, especially later in the day. However, this information is not a diagnostic tool. It cannot predict your exact response to every medication or dietary choice, as many other genes and environmental factors are involved in metabolism. You should never use genetic information to self-diagnose or make significant changes to prescribed medication regimens without consulting your healthcare provider. Always treat genetic data as one piece of a larger puzzle regarding your health, and prioritize professional medical advice when making decisions about your diet, lifestyle, or treatment plans.
How common is this variant?
The rs762551 variant is common across most global populations. Research indicates that approximately half of the population are slow metabolizers (AC or CC genotypes), while the other half are fast metabolizers (AA genotype).
Frequently asked questions
Does my CYP1A2 genotype mean I should stop drinking coffee?
No, your genotype does not dictate whether you should consume coffee. It simply provides information on how your body processes caffeine, which may help you understand your personal sensitivity to it.
Can a DNA test tell me if I am a fast or slow metabolizer?
Yes, many direct-to-consumer genetic tests analyze the rs762551 SNP to categorize individuals as fast or slow metabolizers. However, these results should be interpreted as general information rather than medical advice.
Are there other factors that affect caffeine metabolism?
Yes, caffeine metabolism is influenced by several factors beyond genetics, including smoking status, age, sex, and the use of certain medications that can induce or inhibit the CYP1A2 enzyme.
Is rs762551 the only gene that affects caffeine?
No, caffeine metabolism and intake are polygenic, meaning they are influenced by multiple genes. While CYP1A2 is the primary enzyme, other genes like ADORA2A also play roles in how caffeine affects the body.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4646903?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
This variant in the CYP1A2 gene influences the hepatic metabolism rate of caffeine and is a key marker for individual differences in caffeine clearance.
Intronic marker associated with CYP1A2 enzyme activity and caffeine metabolism rates.
Modulates CYP1A2 inducibility affecting the rate of caffeine metabolism and clearance.
Regulatory variant associated with CYP1A2 enzyme activity, influencing the rate of caffeine metabolism and habitual coffee consumption.
A common variant in the CYP1A2 gene associated with caffeine metabolism rates.
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.